Praxis Precision Medicines, Inc.
PRAX
$366.81
-$1.65-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 10.17% | 28.26% | 37.70% | 57.10% | 131.13% |
| Gross Profit | -10.17% | -28.26% | -58.74% | -58.25% | -134.20% |
| SG&A Expenses | 110.46% | 100.21% | 29.13% | -17.66% | 23.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.39% | 41.66% | 35.88% | 37.14% | 101.00% |
| Operating Income | -27.39% | -41.66% | -51.74% | -37.87% | -102.91% |
| Income Before Tax | -17.70% | -33.57% | -51.52% | -42.43% | -117.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.70% | -33.57% | -51.52% | -42.43% | -117.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.70% | -33.57% | -51.52% | -42.43% | -117.67% |
| EBIT | -27.39% | -41.66% | -51.74% | -37.87% | -102.91% |
| EBITDA | -27.43% | -41.70% | -51.80% | -38.06% | -103.37% |
| EPS Basic | 13.23% | 2.63% | -19.16% | -22.38% | -90.80% |
| Normalized Basic EPS | 13.23% | 3.64% | -14.21% | -22.39% | -90.81% |
| EPS Diluted | 13.23% | 2.63% | -19.16% | -22.38% | -90.80% |
| Normalized Diluted EPS | 13.23% | 3.64% | -14.21% | -22.39% | -90.81% |
| Average Basic Shares Outstanding | 35.65% | 37.18% | 27.16% | 16.38% | 14.08% |
| Average Diluted Shares Outstanding | 35.65% | 37.18% | 27.16% | 16.38% | 14.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |